FGFR3 and neoplasm: Early studies demonstrated that nicotine, a nAChR agonist, promotes tumor initiation and progression in PDAC [116, 117, 118], indicating that parasympathetic nerve‐derived Ach may similarly accelerate tumor growth through nAChR activation.